November 18, 2009
AHA: ARBITER 6-HALTS — Are There Any Clinical Implications?
By a margin of 0.014 mm in carotid intima-media thickness (CIMT), extended-release niacin (Niaspan) demonstrated superiority over ezetimibe (Zetia) as an add-on for high risk patients on long term statin therapy… Stephen Kopecky, MD, a cardiologist at the Mayo Clinic, in Rochester, Minn., said there was no doubt that “surrogate endpoints are being overused. […]
November 17, 2009
Doctors gird for patient anxiety over Zetia data
The good news for Merck & Co’s Zetia cholesterol fighter is that doctors do not seem unduly concerned about its latest setback in a clinical trial. The bad news is they think patient anxiety will cause its sales to drop anyway… Dr. Stephen Kopecky, professor of medicine and cardiovascular disease at the prestigious Mayo […]
Tags: cholesterol, Zetia